Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元

市场透视09-15

北京时间2025年09月15日21时31分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速上涨18.33%。截至发稿，该股报0.320美元/股，成交量4126.03万股，换手率139.54%，振幅3.63%。最近的财报数据显示，该股实现营业收入1.27百万美元，净利润-4.06百万美元，每股收益-0.17美元，毛利139652.00美元，市盈率...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2567107243?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-15 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2567107243","market":"us","top_or_hot":-1,"title":"Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年09月15日21时31分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速上涨18.33%。截至发稿，该股报0.320美元/股，成交量4126.03万股，换手率139.54%，振幅3.63%。最近的财报数据显示，该股实现营业收入1.27百万美元，净利润-4.06百万美元，每股收益-0.17美元，毛利139652.00美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioaffinity Technologies, Inc.股价上涨18.33% 市值涨173.16万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-15 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年09月15日21时31分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速上涨18.33%。截至发稿，该股报0.320美元/股，成交量4126.03万股，换手率139.54%，振幅3.63%。最近的财报数据显示，该股实现营业收入1.27百万美元，净利润-4.06百万美元，每股收益-0.17美元，毛利139652.00美元，市盈率...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIAF","symbol_name":"bioAffinity Technologies, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b","article_id":"2567107243","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915213114a4c78e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2567107243","pubTimestamp":1757943074,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年09月15日21时31分，Bioaffinity Technologies, Inc.股票出现异动，股价快速上涨18.33%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.15%。其相关个股中，Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Prophase Labs, Inc.涨幅较大，Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Ispecimen Inc.较为活跃，换手率分别为1352.22%、139.56%、20.78%，振幅较大的相关个股有Check-Cap Ltd.、Ispecimen Inc.、Precipio, Inc.，振幅分别为37.54%、7.69%、4.21%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BIAF":"bioAffinity Technologies, Inc.","BK4139":"生物科技"},"translate_title":"Bioaffinity Technologies, Inc. stock rose 18.33%, market capitalization rose $1.7316 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIAF":0.9},"content_text":"北京时间2025年09月15日21时31分，Bioaffinity Technologies, Inc.（BIAF.us）股票出现异动，股价快速上涨18.33%。截至发稿，该股报0.320美元/股，成交量4126.03万股，换手率139.54%，振幅3.63%。最近的财报数据显示，该股实现营业收入1.27百万美元，净利润-4.06百万美元，每股收益-0.17美元，毛利139652.00美元，市盈率-0.56倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.15%。其相关个股中，Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Prophase Labs, Inc.涨幅较大，Check-Cap Ltd.、Bioaffinity Technologies, Inc.、Ispecimen Inc.较为活跃，换手率分别为1352.22%、139.56%、20.78%，振幅较大的相关个股有Check-Cap Ltd.、Ispecimen Inc.、Precipio, Inc.，振幅分别为37.54%、7.69%、4.21%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。公司使用能够优先靶向癌细胞和指示疾病状态的细胞群体的技术开发专有的无创诊断测试和癌症治疗药物。公司的产品CyPath Lung是一种用于检测早期肺癌的无创测试。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2567107243","isCrawlerRequest":true}